The women’s health focused company acquired the drug for up to $954 million in 2021 through the acquisition of Forendo Pharma ...

The study, published Tuesday in The Lancet Oncology, focused on women under 55 with and without a uterus. CBS News medical ...

For a condition that affects 10 to 15% of women worldwide, endometriosis research, like most of research about women’s health ...

Organon said on Wednesday it will discontinue the development of its experimental drug, after it failed to reduce pain in women suffering from endometriosis in a mid-stage study.

The study uncovers how ovarian ECM tropism influences endometriotic cell adhesion, paving the way for novel strategies to ...

Lena Dunham is hoping to expand her family soon despite fertility setbacks amid health issues. Dunham, 39, spoke about ...

A drug candidate Organon hailed as perhaps its “biggest potential opportunity” has flunked a phase 2 trial, prompting the company to end clinical development of the endometriosis prospect.

While the classification was made over a decade ago, viral posts on social media have claimed that the birth control pill has ...

Applications are open now through to March 2026 for British Columbia’s publicly funded in-vitro fertilization program.

A landmark 30-year study of over four million women in England has revealed that women with endometriosis-associated ...

A landmark 30-year study of over four million women in England has revealed that women with endometriosis-associated ...